CRANBURY, N.J.--(BUSINESS WIRE)--Physicians’ Education Resource® (PER®) has become a collaborative partner with The Cancer Drug Development Forum (CDDF) for PER®’s 1st Annual European Congress on Genitourinary (GU) Malignancies ™, announced Phil Talamo, president of PER®. The congress will be held June 23-24 in Prague, Czech Republic.
In making the announcement Talamo said “We are excited to join forces with one of world’s leading benefactors in cancer drug research and development. Together, we aim to educate doctors on recent cancer drug development and to have an open discussion about first hand experiences in cancer care and treatment.”
In this collaboration, CDDF will promote PER’s® annual European Congress on Genitourinary Malignancies™ through multiple channels. Additionally, CDDF members will receive a discount to attend the congress, please contact email@example.com to claim your special discount.
The 1st Annual European Congress on Genitourinary Malignancies™ is a practical and interactive multiday program that features a faculty of leading international experts who will provide the latest information and guidance. The event will take place at the Grand Majestic Plaza Hotel, in Prague. For more information or to register, please visit: www.gotoper.com/go/CDDF.
Since 1995, PER® has been the leading provider of live, online and print continuing medical education activities focusing on oncology and hematology by consistently providing high-quality, evidence-based activities that feature leading international experts who focus on the application of practice-changing advances and evolving standards of care in the treatment and management of cancer. In 2017, PER® will develop and implement more than 21 historic annual legacy conferences in the Unites States and Europe, along with many world renown online learning formats, such as Medical Crossfire®, Oncology Consultations®, Oncology Briefings™, Advances in™, Cancer Summaries and Commentaries™, and others. PER® is also the publisher of the monthly peer-reviewed American Journal of Hematology/Oncology® and is accredited by the ACCME and CBRN to educate practicing academic and community-based clinicians on the ever-changing advances occurring in the field of oncology to serve the oncology health care community, including physicians, fellows, advanced practice nurses, nurses, physician assistants, pharmacists and researchers. PER® is part of the Cranbury, N.J.-based Michael J. Hennessy Associates Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.